| EMA[40] | EMA-Placebo[41] | EMA-GM[41] | EMA-G |
---|---|---|---|---|
Patients | 133 | 97 | 95 | 29 |
Median Age | 43 (mean) | 46 | 47 | 51 |
Status of AML | Â | Â | Â | Â |
   Refractory or relapsed <1 yr | 124 (93%) | 61 (64%)* | 59 (61%)* | 11 (38%) |
   Relapsed >1 yr | 9 (7%) | 36 (36%) | 36 (38%) | 3 (10%) |
Secondary AML | 16 (12%) | 16 (16%) | 13 (14%) | 20 (69%) |
ANC > 0.5 × 109/L | 31 days | 37 | 38 | 30 |
CR Rate | 60% | 59% | 65% | 46% |
Toxic Death | 11% | 8% | 5% | 10% |